Physician profile
Joseph Thomas
NPI 1023082039
$926.91
in general payments reported to CMS, 2019-2025
14 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $67.69 · 2023: $16.99 · 2024: $144 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $195.93 | 2019-2025 | Breztri, Airsupra |
| Novo Nordisk INC | $166.63 | 2024-2025 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $153.72 | 2019 | |
| Amgen INC. | $108.96 | 2023-2025 | Repatha, Otezla, Otezla |
| United Therapeutics Corporation | $65.45 | 2025 | Tyvaso |
| Organogenesis INC. | $51.98 | 2019 | |
| Nevro Corp. | $50.02 | 2020 | |
| Ardelyx, INC. | $35.48 | 2024-2025 | Ibsrela |
| Renalytix Ai, INC. | $18.56 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Amarin Pharma, INC. | $17.67 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.60 | 2025 | |
| Lilly USA, LLC | $16.49 | 2024 | Zepbound, Mounjaro |
| Medtronic, INC. | $15.99 | 2025 | Closurefast |
| E.R. Squibb & Sons, L.L.C. | $13.43 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.